Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA

Guinney, 2016, Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data, Lancet Oncol, 18, 132, 10.1016/S1470-2045(16)30560-5 Moreira, 2016, Predicting time from metastasis to overall survival in castration-resistant prostate cancer: results from SEARCH, Clin Genitourin Cancer, 15, 60, 10.1016/j.clgc.2016.08.018 Bertoli, 2016, MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer, Int J Mol Sci, 17, 421, 10.3390/ijms17030421 Leyten, 2014, Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer, Eur Urol, 65, 534, 10.1016/j.eururo.2012.11.014 Fabris, 2016, The potential of MicroRNAs as prostate cancer biomarkers, Eur Urol, 70, 312, 10.1016/j.eururo.2015.12.054 Cooperberg, 2004, The contemporary management of prostate cancer in the united states: lessons from the cancer of the prostate strategic urologic research endeavor (capsure), a national disease registry, J Urol, 171, 1393, 10.1097/01.ju.0000107247.81471.06 Sanguedolce, 2016, Urine TMPRSS2: ERG fusion transcript as a biomarker for prostate cancer: literature review, Clin Genitourin Cancer, 14, 117, 10.1016/j.clgc.2015.12.001 Steurer, 2014, TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer, Eur Urol, 66, 978, 10.1016/j.eururo.2014.06.027 Wang, 2013, Significance of the TMPRSS2:ERG gene fusion in prostate cancer, BJU Int, 111, 834, 10.1111/bju.12120 Nguyenthem, 2016, The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients, Eur J Cancer, 61, 69, 10.1016/j.ejca.2016.03.080 Hwang, 2010, Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma, Proteomics, 6, 2259, 10.1002/pmic.200500345 Sun, 2015, Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer, Br J Cancer, 112, 1332, 10.1038/bjc.2015.114 Harrow, 2012, GENCODE: the reference human genome annotation for The ENCODE Project, Genome Res, 22, 1760, 10.1101/gr.135350.111 Smyth, 2005, Limma: linear models for microarray data, 397 Kolde R., Kolde M.R.Package ‘pheatmap’. Version; 2015. Therneau T., Lumley T.Survival: survival analysis, including penalised likelihood. R package version 2.36-5. Szklarczyk, 2017, The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible, Nucleic Acids Res, 45, D362, 10.1093/nar/gkw937 Kohl, 2011, Cytoscape: software for visualization and analysis of biological networks, Methods Mol Biol, 696, 291, 10.1007/978-1-60761-987-1_18 Kellman, 2010, Multi-contrast delayed enhancement provides improved contrast between myocardial infarction and blood pool, J Magn Reson Imaging, 22, 605, 10.1002/jmri.20426 Bandettini, 2012, MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study, J Cardiovasc Magn Reson, 14, 83, 10.1186/1532-429X-14-83 Wang, 2013, WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013, Nucleic Acids Res, 41, W77, 10.1093/nar/gkt439 Kim, 2016, SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer, Lung Cancer, 99, 57, 10.1016/j.lungcan.2016.05.018 Yang, 2018, SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1865, 1161, 10.1016/j.bbamcr.2018.05.017 Luo, 2017, SRSF2 regulates alternative splicing to drive hepatocellular carcinoma development, Cancer Res, 77, 1168, 10.1158/0008-5472.CAN-16-1919 Kędzierska, 2016, Decreased Expression of SRSF2 splicing factor inhibits apoptotic pathways in renal cancer, Int J Mol Sci, 17, 1598, 10.3390/ijms17101598 Zhang, 2015, Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities, PNAS, 112, 4726, 10.1073/pnas.1514105112 Mcfarlane, 2015, Human papillomavirus 16 oncoprotein expression is controlled by the cellular splicing factor SRSF2 (SC35), J Virol, 89, 5276, 10.1128/JVI.03434-14 Bae, 2015, Human papillomavirus 16 infection as a potential risk factor of prostate cancer: adaptive meta-analysis, Epidemiol Health, 37 Yang, 2015, Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis, Sci Rep, 5, 14667, 10.1038/srep14667 Ogawa, 2014, The probability of involvement of human papillomavirus in the carcinogenesis of bladder small cell carcinoma, prostatic ductal adenocarcinoma, and penile squamous cell carcinoma: a case report, BMC Res Notes, 7, 909, 10.1186/1756-0500-7-909 Ndiaye, 2014, HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis, Lancet Oncol, 15, 1319, 10.1016/S1470-2045(14)70471-1 Fu, 2018, SRSF7 knockdown promotes apoptosis of colon and lung cancer cells, Oncol Lett, 15, 5545 Ma, 2016, Abstract 4542: Ube2d family members, Ube2e family members and Ube2w modulate the ubiquitination and degradation of EGFR by Cbl, Cancer Res, 76, 4542, 10.1158/1538-7445.AM2016-4542 Ma, 2014, Abstract 4441: Ube2e inhibits the ubiquitination and degradation of EGFR mediated by Cbl and Ube2d, Cancer Res, 74, 4441, 10.1158/1538-7445.AM2014-4441 Gan, 2010, Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells, Oncogene, 29, 4947, 10.1038/onc.2010.240 Di, 2002, Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer, Clin Cancer Res, 8, 3438 Chang, 2015, EGF receptor promotes prostate cancer bone metastasis by downregulating miR-1 and activating TWIST1, Cancer Res, 75, 3077, 10.1158/0008-5472.CAN-14-3380 Li, 2016, MicroRNA-495 regulates migration and invasion in prostate cancer cells via targeting Akt and mTOR signaling, Cancer Invest, 34, 181, 10.3109/07357907.2016.1156690 Guo, 2013, The tumor suppressor roles of miR-433 and miR-127 in gastric cancer, Int J Mol Sci, 14, 14171, 10.3390/ijms140714171 Wang, 2017, MicroRNA-495 inhibits gastric cancer cell migration and invasion possibly via targeting high mobility group AT-Hook 2 (HMGA2), Med Sci Monit, 23, 640, 10.12659/MSM.898740 Han, 2017, Disrupted ER‐to‐Golgi trafficking underlies anti‐HIV drugs and alcohol‐induced cellular stress and hepatic injury, Hepatol Commun, 1, 122, 10.1002/hep4.1030 Ramnarayan, 2018, Cytomegalovirus gp40/m152 uses TMED10 as ER anchor to retain MHC Class I, Cell Rep, 23, 3068, 10.1016/j.celrep.2018.05.017 Hou, 2017, Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2, PLoS One, 12, 10.1371/journal.pone.0182995